ArticleJSES international2025
Individualized humeral tray selection in a single design of implant (comprehensive system; Zimmer Biomet, Warsaw, IN) based on clinical symptoms and anatomy enhanced clinical outcomes following reverse total shoulder arthroplasty.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metal-artifact reduced MR imaging for reverse shoulder arthroplasty: findings 1 year after surgery.Skeletal radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recently, a medialized offset eccentric humeral tray was introduced to overcome the complications based on excessive humeral lateralization after reverse total shoulder arthroplasty (rTSA). However, previous literature evaluating the clinical outcomes of the eccentric tray is still not sufficient. Therefore, this study aimed to compare the functional outcomes of rTSA according to individualized humeral tray selection based on clinical symptoms and anatomical parameters. We hypothesized that rTSA with individualized tray selection would result in better clinical outcomes than the routine use of a concentric or eccentric tray regardless of clinical or radiological findings. Methods: We retrospectively reviewed 182 patients who underwent rTSA with a single type of lateralized glenoid-lateralized humerus implant with adjustable tray options (Comprehensive System; Zimmer Biomet, Warsaw, IN, USA) between September 2017 and March 2022. Since the eccentric tray became available for use in December 2019, patients before (early period) and after this date (late period) were divided into four groups based on the study period and humeral tray options; Groups EE (early period, indicated for eccentric tray but not applied), EC, LE (late period, eccentric tray), and LC (late period, concentric tray). The eccentric tray was indicated to overcome pseudoparalysis, meanwhile, the concentric tray was utilized in patients with positive external rotation lag sign without pseudoparalysis. If a patient had neither pseudoparalysis nor external rotation lag sign, the eccentric tray was utilized in patients with a critical shoulder angle less than 32° or center of rotation-to-acromion distance more than 14 mm. Functional and radiological outcomes were compared between four groups. The mean follow-up duration for the overall cohort was 12.8 ± 2.0 months (range: 12-24). Results: Compared to EE, LE presented greater distalization (EE vs. LE 29.0 ± 5.0 mm vs. 38.0 ± 4.0 mm, Conclusion: To achieve favorable outcomes and avoid postoperative complications, the mediolateral offset of the humeral tray for lateralized rTSA should be selected based on a comprehensive consideration of clinical symptoms and anatomical characteristics of individual patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.